Sheikh Rayees Yousuf, Murdeshwar Soni, Maheshwari Teerath Kumar, Chacko Saramma
Department of Nephrology and Bahrain Specialist Hospital, Manama, Bahrain.
Department of Microbiology, Bahrain Specialist Hospital, Manama, Bahrain.
Saudi J Kidney Dis Transpl. 2022 Feb;33(Supplement):S53-S60. doi: 10.4103/1319-2442.374382.
Urinary tract infection is the second-most common after respiratory infections. This is a single-center retrospective study conducted in Bahrain Specialist Hospital, Bahrain. Urine culture data from November 2011 until December 2020 was obtained from the hospital database. Out of 28082, 4849 (17.3%) cultures were positive. One hundred and thirty-four (2.8%) showed the growth of multiple organisms. The male-to-female ratio was 3.7. Most of the patients [1872 (39.7%)] were 20-40 years. Men and women were 53.84 ± 25.85 and 43.41 ± 23.89 years, respectively; P <0.001. 4118/4715 (87.3%) were Gram-negative. Five hundred and sixty-four (11.9 %) and 33 (0.7%) were Gram-positive cocci and fungi, respectively. Escherichia coli (E. coli) was the most common and Klebsiella species were second-most common, accounting for 2916 (61.8%) and 586 (12.4%), respectively. 30.2% of all E. coli and 130 (22.2%) of all Klebsiella species were extended-spectrum beta-lactamase (ESBL) producers. ESBL Klebsiella pneumoniae, Pseudomonas aeruginosa, and Enterococcus faecalis were present more in inpatients (P <0.001). P. aeruginosa was found more in women (P <0.001). E. coli was resistant to cotrimoxazole, ciprofloxacin, and levofloxacin in 28%, 17.3%, and 18.1%, respectively. ESBL E. coli and ESBL K. pneumoniae were resistant to amoxicillin-clavulanate, cotrimoxazole, ciprofloxacin, and levofloxacin in 73.8%, 62.3%, 62.4%, 58.4% and 68.2%, 62.6%, 55.7%, and 41.8% respectively. There is a high incidence of ESBL E. coli and ESBL K. pneumoniae. There is alarmingly increased resistance of P. aeruginosa to carbapenems. Amoxicillin-clavulanate, cefixime, and cefuroxime are suitable oral antibiotics for empirical treatment. For sick patients, piperacillin-tazobactam, aminoglycosides, and carbapenems should be considered. Antibiotic stewardship is the need of an hour.
尿路感染是仅次于呼吸道感染的第二常见感染。这是一项在巴林专科医院进行的单中心回顾性研究。从医院数据库中获取了2011年11月至2020年12月的尿培养数据。在28082份样本中,4849份(17.3%)培养结果呈阳性。134份(2.8%)显示有多种微生物生长。男女比例为3.7。大多数患者[1872例(39.7%)]年龄在20至40岁之间。男性和女性的年龄分别为53.84±25.85岁和43.41±23.89岁;P<0.001。4118/4715(87.3%)为革兰氏阴性菌。革兰氏阳性球菌和真菌分别占564份(11.9%)和33份(0.7%)。大肠埃希菌(大肠杆菌)最为常见,克雷伯菌属次之,分别占2916份(61.8%)和586份(12.4%)。所有大肠杆菌中有30.2%以及所有克雷伯菌属中有130份(22.2%)产超广谱β-内酰胺酶(ESBL)。产ESBL的肺炎克雷伯菌、铜绿假单胞菌和粪肠球菌在住院患者中更为常见(P<0.001)。铜绿假单胞菌在女性中更为常见(P<0.001)。大肠杆菌对复方新诺明、环丙沙星和左氧氟沙星的耐药率分别为28%、17.3%和18.1%。产ESBL的大肠杆菌和产ESBL的肺炎克雷伯菌对阿莫西林-克拉维酸、复方新诺明、环丙沙星和左氧氟沙星的耐药率分别为73.8%、62.3%、62.4%、58.4%和68.2%、62.6%、55.7%和41.8%。产ESBL的大肠杆菌和产ESBL肺炎克雷伯菌的发生率较高。令人担忧的是,铜绿假单胞菌对碳青霉烯类药物的耐药性增加。阿莫西林-克拉维酸、头孢克肟和头孢呋辛是适用于经验性治疗的口服抗生素。对于病情较重的患者,应考虑使用哌拉西林-他唑巴坦、氨基糖苷类药物和碳青霉烯类药物。抗生素管理是当务之急。